He leads the Genetics and Computational Biology Group and his main scientific interests revolve around the investigation of genetic polymorfisms, genetic variability in viral strains and the in silico drug design of novel antiviral and anticancer agents. To date, Dr. Vlachakis has published more than 90 original research articles in international peer-reviewed journals with impact factor, 100+ articles in international conference proceedings, 5 monograph ISBN books, 2 scientific patents and has been on the receiving end of numerous grants and awards. Since 2012 Dr. Vlachakis has been serving as the Editor in Chief and Associate Editor of relevant international journals.